HOW TO REFER A PATIENT FOR A CLINICAL TRIAL?
An overview of early clinical research performed by the Early Drug Development Center (EDDC) can be found here. You can browse the clinical trials to find out about main criteria of in/exclusion, intervention, goals, and research design.
It is also possible to fill out this referral form if you want to directly refer your patient for a clinical trial. The form will be processed by our planning department once it has been completed and all the required documents are submitted. After processing, a specialized doctor from EDDC will have a consultation with your patient to see whether there is a match with the inclusion criteria. The doctor and patient will discuss which clinical trial is suitable according to their physical condition and disease characteristics.
If you have any questions about a phase 1 or 2 clinical trial, please send an email to phase1@eddc-nki.com. You can also send us an email if you would like to consult any of our experts about clinical trials. You can find more information about patient eligibility for clinical trials here.
If you would like to be informed about ongoing or upcoming clinical trials, you can sign up for our quarterly newsletter, which contains the latest developments.
It is also possible to fill out this referral form if you want to directly refer your patient for a clinical trial. The form will be processed by our planning department once it has been completed and all the required documents are submitted. After processing, a specialized doctor from EDDC will have a consultation with your patient to see whether there is a match with the inclusion criteria. The doctor and patient will discuss which clinical trial is suitable according to their physical condition and disease characteristics.
If you have any questions about a phase 1 or 2 clinical trial, please send an email to phase1@eddc-nki.com. You can also send us an email if you would like to consult any of our experts about clinical trials. You can find more information about patient eligibility for clinical trials here.
If you would like to be informed about ongoing or upcoming clinical trials, you can sign up for our quarterly newsletter, which contains the latest developments.
